AudioCure Pharma Advances Trial Testing of AC102 for Sudden Hearing Loss Treatment
AudioCure Pharma has surpassed 50% patient enrollment in its Phase 2 trial testing AC102, a novel therapy to treat sudden hearing loss.
AudioCure Pharma has surpassed 50% patient enrollment in its Phase 2 trial testing AC102, a novel therapy to treat sudden hearing loss.